Authors
Loading...
Review uncovers epigenetic mechanisms driving hepatic stellate cell activation in liver fibrosis, highlighting novel therapeutic targets for experimental chronic liver disease.
Tavaf et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: